|
|||||
|
|
| 上市后中成药再评价临床定位的原则和方法——基于循证医学的理念 | |
| 引用本文： | 商洪才,张伯礼,李幼平.上市后中成药再评价临床定位的原则和方法——基于循证医学的理念[J].中西医结合学报,2008,6(9):887-890. |
| 作者姓名： | 商洪才 张伯礼 李幼平 |
| 作者单位： | 1. 四川大学华西医院临床医学博士后流动站,四川成都610041;天津中医药大学循汪医学中心,天津300193;天津中医药大学中医药研究院,天津300193 2. 天津中医药大学中医药研究院,天津,300193 3. 四川大学华西医院临床医学博士后流动站,四川成都,610041 |
| 基金项目： | 国家自然科学基金，中国博士后科学基金 |
| 摘 要： | 针对当前名优中药二次开发过程中普遍存在的临床定位不清的弊端，剖析了导致中药品种临床定位不清的主要原因，阐明了临床定位在名优中药品种二次开发中的必要性。基于循证医学的理念，提出了中成药上市后再评价临床定位的确定原则、方法和步骤，为名优中成药二次开发的顺利实施奠定了理论基础和方法保证。 |
| 关 键 词： | 中成药 药物评价 临床定位 循证医学 |
Clinical orientation of post-marketing Chinese patent drugs:an evidence-based practice |
|
| Hong-cai SHANG,Bo-li ZHANG,You-ping LI.Clinical orientation of post-marketing Chinese patent drugs:an evidence-based practice[J].Journal of Chinese Integrative Medicine,2008,6(9):887-890. | |
| Authors: | Hong-cai SHANG Bo-li ZHANG You-ping LI |
| Institution: | Postdoctoral Station of Clinical Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China; E-mail: shanghongcai@126.com. |
| Abstract: | Unclear clinical orientation in practice has become one of the common problems with the effective application of famous and excellent Chinese herbal drugs, consequently restricting their development. The authors suggest that there are three aspects to be considered in dealing with this problem. Clinical evaluation and orientation of the famous and excellent Chinese herbal drugs is an important task, and it is also a requirement for the internationalization of traditional Chinese medicine. Literature evaluation-pharmacology research-clinical expertise analysis method will establish a theoretical basis and method for post-marketing development of famous and excellent Chinese patent drugs. |
| Keywords: | Chinese patent drugs drug evaluation clinical orientation evidence-based medicine |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |